Ducommun Incorporated

Ducommun Incorporated unveiled its VISION 2032 strategic growth plan at its first Investor Day in nearly four years, building on a VISION 2027 plan the company says it is on track to meet or exceed. Chairman, President and CEO Stephen G. Oswald confirmed the three core VISION 2027 targets set in December 2022: revenue reaching approximately $950 million or more by 2027, Adjusted EBITDA margins expanding to roughly 18%, and higher-margin Engineered Products rising to about 25% of total revenue. Under VISION 2032, Ducommun is increasing its acquisition range by up to 3 to 5 times, targeting acquisitions in the $300 million to $500 million range while continuing bolt-on deals, and projects a mid-teens compound annual growth rate through 2032 for its core missile and radar franchise. The company said it is positioned to capture commercial aerospace volume recovery across major narrowbody platforms with minimal required capital expenditure, and will keep investing organically in proprietary Engineered Products. Since the end of 2022, Ducommun has delivered total shareholder return of 245%, with market capitalization rising from $605 million to $2.6 billion and average daily traded value increasing from about $2 million to $49 million. Analysts from Citi, RBC and Goldman Sachs commented positively at the event, with Goldman Sachs noting Ducommun has unique positions on growth verticals and stating it is Buy rated on the stock.

Ducommun Incorporated shares have surged 104% year-to-date as of August 7, driven by a ramp-up in commercial aerospace and defense programs. The company reported record second-quarter net revenue of $224.5 million, up 12% year-over-year, with gross margin expanding 160 basis points to a record 28%. Adjusted EBITDA grew 21% to 17.1% of revenue, and non-GAAP adjusted net income rose 35% to $18.4 million, with diluted earnings per share of $1.18 beating estimates of $0.98. Remaining Performance Obligations reached an all-time high of $1.2 billion, and bookings of $309.7 million produced a book-to-bill of 1.4x. Management expects destocking headwinds in the back half of the fiscal year, and the stock's forward price-earnings ratio of 48.44 is well above the sector median of 21.19.

Aerospace and defense stocks delivered a very strong first quarter, with aggregate revenues beating analyst consensus estimates by 2.8% and next-quarter revenue guidance coming in 3.6% above expectations. Axon reported revenues of $807.3 million, up 33.7% year on year and exceeding estimates by 3.7%, while Rocket Lab posted revenues of $200.3 million, a 63.5% increase that beat expectations by 4.9% and delivered the highest guidance raise among its peers. AerSale was the weakest performer, with revenues of $70.61 million falling short of estimates by 18.9%. Ducommun and Howmet also reported beats, with revenues of $209 million and $2.31 billion respectively. Share prices across the group have held steady, rising 3.5% on average since the latest earnings results.

Ducommun Incorporated reported first-quarter 2026 net revenue of $209 million, a 9% increase from the prior year. Gross margin expanded 70 basis points to 26.9%, and adjusted net income reached $0.75 per share, up from $0.23 in the first quarter of 2025. Truist raised its price target on the stock to $150 from $136 with a Buy rating after the earnings beat, while Citigroup lifted its target to $167 from $141, also reiterating a Buy rating. The company, which provides manufacturing solutions for aerospace, defense, and industrial markets, has seen its shares surge over 70% this year.